Page last updated: 2024-08-26

cilastatin and Leukocytopenia

cilastatin has been researched along with Leukocytopenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K1
Fujita, K; Hatae, Y; Kon-No, M; Nagashima, T; Nakadate, H; Suzuki, Y; Takahashi, Y; Takase, A; Takeda, T; Wagatsuma, Y1
Bruserud, O1

Trials

1 trial(s) available for cilastatin and Leukocytopenia

ArticleYear
[A multi-institutional study on the efficacy and toxicity of imipenem/cilastatin sodium in severe infections complicating hematological diseases and cancers in children. Study Group of Infectious Diseases in Pediatric Hematology/Oncology in Hokkaido].
    The Japanese journal of antibiotics, 1993, Volume: 46, Issue:5

    Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Infant; Leukemia; Leukopenia; Male; Neoplasms; Pneumonia; Sepsis

1993

Other Studies

2 other study(ies) available for cilastatin and Leukocytopenia

ArticleYear
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins

2004
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
    International journal of immunopharmacology, 2000, Volume: 22, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cilastatin; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Interleukin-2; Leukemia, Myeloid, Acute; Leukopenia; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes

2000